VACCINE-INDUCTED THROMBOTIC THROMBOCYTOPENIA AND COVID-19 VACCINES: CASE SERIES

Abstract

Vaccine-induced thrombotic thrombocytopenia (VITT) is a condition similar to heparin-induced throm- bocytopenia (HIT), but it is associated with prior administration of COVID-19 vaccines without prior exposure to heparin. The incidence of VITT is not certain, but it appears to be extremely rare. Reports of unusual and severe thrombotic events, including cerebral and splanchnic venous thrombosis and other autoimmune adverse reactions, such as immune thrombocytopenia or thrombotic microangiopathies in connection with some of the SARS-CoV-2 vaccines, have caused a great deal of concern within the pop- ulation and the medical community. We would like to present 4 clinical cases of VITT, hospitalized and treated in intensive care unit (ICU) of University clinic of cardiology in Skopje.